Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers

Journal of the National Cancer Institute

Volumn 98, Issue 5, 2006, Pages 335-344

  Dreher, Matthew R ^a   Liu, Wenge ^a   Michelich, Charles R ^a   Dewhirst, Mark W ^b   Yuan, Fan ^a   Chilkoti, Ashutosh ^a,c  

^a Duke University   (United States)

^b DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN; DEXTRAN 40; DEXTRAN 70; DRUG CARRIER;

ANIMAL MODEL; AREA UNDER THE CURVE; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VESSEL WALL; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVALENT BOND; DRUG ACCUMULATION; DRUG DELIVERY SYSTEM; DRUG HALF LIFE; DRUG PENETRATION; DRUG TUMOR LEVEL; HUMAN; HUMAN CELL; IMAGE ANALYSIS; KRUSKAL WALLIS TEST; LASER MICROSCOPY; MACROMOLECULE; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; STATISTICAL SIGNIFICANCE; TUMOR VASCULARIZATION;

ANIMALS; ANTINEOPLASTIC AGENTS; CAPILLARY PERMEABILITY; CARCINOMA, SQUAMOUS CELL; DEXTRANS; DRUG CARRIERS; FLUORESCENCE; HALF-LIFE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MATHEMATICAL COMPUTING; MICE; MICE, INBRED BALB C; MICE, NUDE; MICROSCOPY, CONFOCAL; MOLECULAR WEIGHT; PLASMA SUBSTITUTES;

EID: 33644772618     PISSN: 00278874     EISSN: 14602105     Source Type: Journal    
DOI: 10.1093/jnci/djj070     Document Type: Article

References (68)

1. Jain RK. Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 2001;46:149-68.
2. Moses MA, Brem H, Langer R. Advancing the field of drug delivery: Taking aim at cancer. Cancer Cell 2003;4:337-41.
3. Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004;303:1818-22.
4. Ehrlich P. Collected studies on immunity. 1st ed. New York (NY): John Wiley and Sons; 1906.
5. Torchilin VP. Recent advances with liposomes as pharmaceutical carriers. Nat Rev Drug Discov 2005;4:145-60.
6. Kataoka K, Harada A, Nagasaki Y. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Deliv Rev 2001;47:113-31.
7. Senter PD, Springer CJ. Selective activation of anticancer prodrugs by monoclonal antibody-enzyme conjugates. Adv Drug Deliv Rev 2001;53: 247-64.
8. Vrouenraets MB, Visser GWM, Snow GB, van Dongen G. Basic principles, applications in oncology and improved selectivity of photodynamic therapy. Anticancer Res 2003;23:505-22.
9. Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002;2:750-63.
10. Kopecek J, Kopeckova P, Minko T, Lu Z. HPMA copolymer-anticancer drug conjugates: Design, activity, and mechanism of action. Eur J Pharm Biopharm 2000;50:61-81.
11. Duncan R. The dawning era of polymer therapeutics. Nat Rev Drug Discov 2003;2:347-60.
12. Lewis WH. The vascular pattern of tumors. Bull Johns Hopkins Hosp 1927;41:156-62.
13. Sandison JC. Observations on the growth of blood vessels as seen in the transparent chamber introduced into the rabbit's ear. Am J Anat 1928; 41:475-96.
14. Ide AG, Baker NH, Warren SL. Vascularization of the Brown-Pearce rabbit epithelioma transplant as seen in the transparent ear chamber. Am J Roentgenol 1939;42:891-9.
15. Algire GH, Chalkley HW, Legallais FY, Park HD. Vascular reactions of normal and malignant tissues in vivo: Vascular reactions of mice to wounds and to normal and neoplastic transplants. J Natl Cancer Inst 1945;6:73-85.
16. Duran-Reynals F. Studies on the localization of dyes and foreign proteins in normal and malignant tissue. Am J Cancer 1939;35:98-107.
17. Babson AL, Winnick T. Protein transfer in tumor-bearing rats. Cancer Res 1954;14:606-11.
18. Busch H, Greene HSN. Studies on the metabolism of plasma proteins in tumor-bearing rats. Yale J Biol Med 1955;27:339-49.
19. Dewey WC. Vascular-extravascular exchange of plasma proteins in the rat. Am J Physiol 1959;197:423-31.
20. Song CW, Levitt SH. Quantitative study of the vascularity in Walker carcinoma 256. Cancer Res 1971;31:587-9.
21. Underwood JCE, Carr I. The ultrastructure and permeability characteristics of the blood vessel of a transplantable rat sarcoma. J Pathol 1972;107:157-66.
22. Peterson H-I, Appelgren KL. Experimental studies on the uptake and retention of labeled proteins in a rat tumor. Eur J Cancer 1973;9:543-7.
23. Heuser LS, Miller FN. Differential macromolecular leakage from the vasculature of tumors. Cancer 1986;57:461-4.
24. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvasc Res 1986;31:288-305.
25. Dvorak HF, Nagy JA, Dvorak JT, Dvorak AM. Identification and characterization of the blood vessels of solid tumors that are leaky to circulating macromolecules. Am J Pathol 1988;133:95-109.
26. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986;46:6387-92.
27. Maeda H, Matsumura Y. Tumoritropic and lymphotropic principles of macromolecular drugs. Crit Rev Ther Drug Carrier Syst 1989;6:193-210.
28. Maeda H, Seymour LW, Miyamoto Y. Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjug Chem 1992;3:351-62.
29. Seymour LW. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit Rev Ther Drug Carrier Syst 1992;9:135-87.
30. Ringsdorf H. Structure and properties of pharmacologically active polymer. J Polymer Sci Polymer Symp 1975;51:135-53.
31. Tomlinson E. Passive and active vectoring with microparticles: localization and drug release. J Control Release 1985;2:385-91.
32. Sung C, Youle RJ, Dedrick RL. Pharmacokinetic analysis of immunotoxin uptake in solid tumors: Role of plasma kinetics, capillary-permeability, and binding. Cancer Res 1990;50:7382-92.
33. Tabata Y, Kawai T, Murakami Y, Ikada Y. Electric charge influence of dextran derivatives on their tumor accumulation after intravenous injection. Drug Deliv 1997;4:213-21.
34. w) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats. J Biomed Mater Res 1987;21:1341-58.
35. Yamaoka T, Tabata T, Ikada Y. Body distribution profile of polysaccharides after intravenous administration. Drug Deliv 1993;1:75-82.
36. Takakura Y, Hashida M. Macromolecular carrier systems for targeted drug delivery: Pharmacokinetic considerations on biodistribution. Pharm Res 1996;13:820-31.
37. Murakami Y, Tabata Y, Ikada Y. Tumor accumulation of poly(ethylene glycol) with different molecular weights after intravenous injection. Drug Deliv 1997;4:23-31.
38. Tabata T, Murakami Y, Ikada Y. Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection. J Control Release 1998;50: 123-33.
39. Noguchi Y, Wu J, Duncan R, Strohalm J, Ulbrich K, Akaike T, et al. Early phase tumor accumulation of macromolecules: A great difference in clearance rate between tumor and normal tissues. Jpn J Cancer Res 1998;89:307-14.
40. Seymour LW, Miyamoto Y, Maeda H, Brereton M, Strohalm J, Ulbrich K, et al. Influence of molecular-weight on passive tumor accumulation of a soluble macromolecular drug carrier. Eur J Cancer 1995;31A:766-70.
41. Michel CC, Curry FE. Microvascular permeability. Physiol Rev 1999;79: 703-61.
42. Yuan F, Dellian M, Fukumura D, Leunig M, Berk DA, Torchilin VP, et al. Vascular permeability in a human tumor xenograft: Molecular size dependence and cutoff size. Cancer Res 1995;55:3752-6.
43. Pluen A, Boucher Y, Ramanujan S, McKee TD, Gohongi T, di Tomaso E, et al. Role of tumor-host interactions in interstitial diffusion of macromolecules: Cranial vs. subcutaneous tumors. Proc Natl Acad Sci U S A 2001;98: 4628-33.
44. Papenfuss HD, Gross JF, Intaglietta M, Treese FA. Transparent access chamber for the rat dorsal skin fold. Microvasc Res 1979;18:311-8.
45. Truskey GA, Yuan F, Katz DF. Transport phenomena in biological systems. Upper Saddle River (NJ): Prentice Hall; 2004.
46. Brizel DM, Klitzman B, Cook JM, Edwards J, Rosner G, Dewhirst MW. A comparison of tumor and normal tissue microvascular hematocrits and red-cell fluxes in a rat window chamber model. Int J Radiat Oncol Biol Phys 1993;25:269-76.
47. Krol A, Maresca J, Dewhirst MW, Yuan F. Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: Implications for drug delivery. Cancer Res 1999;59:4136-41.
48. Yuan F, Krol A, Tong S. Available space and extracellular transport of macromolecules: Effects of pore size and connectedness. Ann Biomed Eng 2001;29:1150-8.
49. Berk DA, Yuan F, Leunig M, Jain RK. Fluorescence photobleaching with spatial Fourier-analysis: Measurement of diffusion in light-scattering media. Biophys J 1993;65:2428-36.
50. Lebrun L, Junter GA. Diffusion of sucrose and dextran through agar gel membranes. Enzyme Microb Technol 1993;15:1057-62.
51. Bernstein A, Hurwitz E, Maron R, Arnon R, Sela M, Wilchek M. Higher antitumor efficacy of daunomycin when linked to dextran: In vivo and in vitro studies. J Natl Cancer Inst 1978;60:379-84.
52. Wu NZ, Klitzman B, Rosner G, Needham D, Dewhirst MW. Measurement of material extravasation in microvascular networks using fluorescence video-microscopy. Microvasc Res 1993;46:231-53.
53. Yuan F, Leunig M, Berk DA, Jain RK. Microvascular permeability of albumin, vascular surface-area, and vascular volume measured in human adenocarcinoma LS174T using dorsal chamber in SCID mice. Microvasc Res 1993;45:269-89.
54. Brown EB, Campbell RB, Tsuzuki Y, Xu L, Carmeliet P, Fukumura D, et al. In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy [erratum in Nat Med 2001;7:1069]. Nat Med 2001; 7:864-8.
55. Hashizume H, Baluk P, Morikawa S, McLean JW, Thurston G, Roberge S, et al. Openings between defective endothelial cells explain tumor vessel leakiness. Am J Pathol 2000;156:1363-80.
56. Dvorak AM, Feng D. The vesiculo-vacuolar organelle (VVO): A new endothelial cell permeability organelle. J Histochem Cytochem 2001;49: 419-31.
57. Fujimori K, Covell DG, Fletcher JE, Weinstein JN. A modeling analysis of monoclonal antibody percolation through tumors: A binding-site barrier. J Nucl Med 1990;31:1191-8.
58. Juweid M, Neumann R, Paik C, Perezbacete MJ, Sato J, Vanosdol W, et al. Micropharmacology of monoclonal antibodies in solid tumors: Direct experimental evidence for a binding-site barrier. Cancer Res 1992;52: 5144-53.
59. Wijffels K, Kaanders J, Marres HAM, Bussink J, Peters HPW, Rijken P, et al. Patterns of proliferation related to vasculature in human head-and-neck carcinomas before and after transplantation in nude mice. Int J Radiat Oncol Biol Phys 2001;51:1346-53.
60. Satchi-Fainaro R, Mamluk R, Wang L, Short SM, Nagy JA, Feng D, et al. Inhibition of vessel permeability by TNP-470 and its polymer conjugate, caplostatin. Cancer Cell 2005;7:251-61.
61. Satchi-Fainaro R, Puder M, Davies JW, Tran HT, Sampson DA, Greene AK, et al. Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470. Nat Med 2004;10:255-61.
62. Ulbrich K, Subr V, Strohalm J, Plocova D, Jelinkova M, Rihova B. Polymeric drugs based on conjugates of synthetic and natural macromolecules. I. Synthesis and physico-chemical characterization. J Control Release 2000;64:63-79.
63. Ulbrich K, Etrych T, Chytil P, Jelinkova M, Rihova B. HPMA copolymers with pH-controlled release of doxorubicin: In vitro cytotoxicity and in vivo antitumor activity. J Control Release 2003;87:33-47.
64. Charrois GJR, Allen TM. Rate of biodistribution of STEALTH liposomes to tumor and skin: Influence of liposome diameter and implications for toxicity and therapeutic activity. Biochim Biophys Acta 2003; 1609:102-8.
65. Charrois GJR, Allen TM. Drug release rate influences the pharmacokinetics, biodistribution, therapeutic activity, and toxicity of PEGylated liposomal doxorubicin formulations in murine breast cancer. Biochim Biophys Acta 2004;1663:167-77.
66. Burchard W, Schmidt M, Stockmayer WH. Information on polydispersity and branching from combined quasi-elastic and integrated scattering. Macromolecules 1980;13:1265-72.
67. Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP, et al. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci U S A 1998;95:4607-12.
68. Harris JM, Chess RB. Effect of PEGylation on pharmaceuticals. Nat Rev Drug Discov 2003;2:214-21.